Jointral

Ibuprofen lysine, the active ingredient in Jointral, is a nonsteroidal anti‑inflammatory drug presented as a topical formulation for cutaneous application directly on the affected area. It is used to alleviate mild to moderate musculoskeletal pain, reduce localized inflammation, and provide analgesia for minor injuries such as sprains, strains, bruises and improve functional mobility.

GNH USA supplies Jointral as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable logistics for global distribution.

Jointral, a topical NSAID, acts on inflammatory pathways to relieve pain and swelling in musculoskeletal and localized conditions. - Mild to moderate musculoskeletal pain: reduces pain and improves movement in muscles, joints and tendons. - Localized inflammatory conditions: diminishes swelling and redness in areas such as tendonitis or bursitis. - Minor injuries (sprains, strains, bruises): provides targeted analgesia and inflammation control on the skin surface.

Topical ibuprofen lysine may cause local skin reactions and, rarely, systemic adverse events.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Itching: localized pruritus following use. - Burning sensation: transient warmth or stinging. - Dryness: mild desiccation of the skin. - Erythema: slight reddening of the treated area. - Pruritus: occasional itching.

Serious or Rare Side Effects: - Allergic dermatitis: severe rash or swelling requiring medical attention. - Stevens‑Johnson syndrome: rare but serious skin reaction. - Systemic NSAID effects: rare gastrointestinal upset or renal impact if absorbed in large amounts. - Contact urticaria: hives developing on contact. - Severe skin necrosis: extremely rare tissue damage. - Anaphylaxis: life‑threatening allergic response (very rare).

Before using Jointral, consider the following safety measures. - Assess skin integrity: ensure the skin is intact and free of open wounds. - Avoid use on broken skin: do not apply to cuts, abrasions or ulcerated areas. - Limit application area: restrict use to the recommended surface area to minimize systemic absorption. - Do not exceed recommended frequency: follow label instructions regarding how often to apply. - Monitor for systemic NSAID effects: watch for signs of gastrointestinal discomfort or renal changes, especially with extensive use. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Topical ibuprofen lysine can interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concurrent systemic NSAIDs: increased risk of additive toxicity and gastrointestinal effects. - Anticoagulants (e.g., warfarin): heightened bleeding tendency. - Corticosteroid creams: potential for enhanced skin thinning and irritation.

Moderate Interactions (Monitor Closely): - Other topical agents: may alter absorption or increase irritation. - Lithium therapy: possible increase in lithium serum levels. - Methotrexate: potential additive toxicity, especially with extensive skin application.